Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19 polymorphisms and clopidogrel clinical efficacy in elderly patients with coronary heart disease
ChiCTR-OCS-12001901Phase 4Completed
- Sponsor
- Administration of Science, Technology and Training
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in coronary arteriosclerosis, sponsored by Administration of Science, Technology and Training. Primary endpoints: Drug-metabolizing enzyme polymorphisms, Drug-drug interaction and 1 more. Started Apr 2011; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-OCS-12001901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCS-12001901.